Research programme: anticancer therapeutics - BioceltranAlternative Names: Photodynamic therapy and protein transduction technology derived anticancer therapeutics - Bioceltran; PTD/PDT anticancer therapeutics - Bioceltran
Latest Information Update: 12 Nov 2014
At a glance
- Originator Bioceltran
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer